On the combination of Chinese and Western medicine to improve efficacy in postmenopausal osteoporosis Experience.docVIP

 PAGE \* MERGEFORMAT 13 On the combination of Chinese and Western medicine to improve efficacy in postmenopausal osteoporosis Experience Keywords: post-menopausal osteoporosis;,, combining Chinese and Western medicine;, and clinical experience Keywords:: Postmenopausal osteoporosis; Zhong Xi Yi Jie; Clinical Experience Postmenopausal osteoporosis, the main object is involved in postmenopausal women, the prevalence rate of 5% to 20%, the peak age of onset 60 to 70 years old. Clinical treatment, estrogen, VitD3 class, bisphosphonates, calcitonin and other drugs have better clinical effect, but due to cost, side effects, health care concepts and other reasons, many medicines are not widely in clinical application of . Chinese medicine treatment of this disease have a positive effect, combining Chinese and Western medicine prevention and treatment of this disease have a positive practical significance. Western medicine, an understanding of this disease Cause of postmenopausal osteoporosis is mainly due to estrogen deficiency, VitD3 forming insufficient secondary parathyroid hormone insufficiency. Bone is in a continually updated into the living tissue, this process is called bone remodeling, bone reconstruction process affected by many factors, the regulation, including hormone regulation, nutrition and living habits, genetic, immune function, exercise and other factors in the original onset of osteoporosis plays an important role in the occurrence. There is no form of treatment has been effective in reversing loss of bone mass, early prevention is more important. Sub-therapeutic drugs inhibit bone resorption and promote bone formation in two major categories of drugs inhibit bone resorption are estrogen, calcitonin, bisphosphonates and selective estrogen receptor modulators, promoting bone formation drugs fluoride , the male hormones, clinical efficacy uncertain, is the commonly used clinical drugs that inhibit bone resorption.